Memphasys explores new applications in agriculture

Memphasys (ASX:MEM) has announced the start of a scoping study to examine the use of its RoXsta™ System in cattle breeding. This initiative aims to assess oxidative stress levels in cattle and their correlation with reproductive success. Conducted at a commercial operation in New South Wales, the study involves 50 heifers and plans to deliver preliminary pregnancy results by late February 2025.

Overview and future potential for Memphasys

Memphasys has embarked on a scoping study to explore the applicability of its RoXsta™ System in cattle breeding, focusing on oxidative stress and reproductive outcomes. The research, set in New South Wales, involves testing 50 heifers, with preliminary results anticipated by February 2025. The study aims to validate the hypothesis that antioxidant levels affect reproductive success. If successful, it may lead to a larger clinical trial with the University of Newcastle in Autumn 2025. Memphasys aims to enhance livestock productivity, potentially expanding its footprint in the agricultural sector by providing solutions to reproductive challenges in cattle.

Insights from Memphasys on the study

David Ali, Managing Director and CEO of Memphasys, expressed enthusiasm about the potential of the RoXsta™ System to improve livestock productivity and the prospects of a larger-scale trial.